A Study of Nivolumab in Participants With Locally Advanced or Metastatic (Stage IIIB-IV) Non-Small Cell Lung Cancer (NSCLC) With Squamous and Non-Squamous Histology After Prior Chemotherapy Treated in Real World Settings in Greece and Cyprus
Condition:   Non-Small Cell Lung Cancer Intervention:   Sponsor:   Bristol-Myers Squibb Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 5, 2021 Category: Research Source Type: clinical trials

Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer
Conditions:   Prostate Adenocarcinoma;   Radiation Toxicity Interventions:   Radiation: External beam radiation therapy, High-dose-rate brachytherapy;   Drug: Goserelin 10.8 mg Sponsor:   German Oncology Center, Cyprus Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2021 Category: Research Source Type: clinical trials